|
|
Volumn 20, Issue 1, 1999, Pages 97-99
|
|
How frequently should viral load be monitored to evaluate antiretroviral therapies in AIDS clinical trials? [4]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DIAGNOSTIC VALUE;
DRUG POTENCY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
LETTER;
MATHEMATICAL MODEL;
PRIORITY JOURNAL;
VIRUS LOAD;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0032900151
PISSN: 10779450
EISSN: None
Source Type: Journal
DOI: 10.1097/00042560-199901010-00017 Document Type: Letter |
|
Times cited : (2)
|
|
References (14)
|
